XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Contributed capital
Contributed capital
Cumulative effect of accounting changes
Accumulated deficit
Accumulated deficit
Cumulative effect of accounting changes
Treasury stock
Accumulated other comprehensive (loss) income
Beginning Balance (in shares) at Dec. 31, 2021   3,955,000              
Beginning Balance (in shares) at Dec. 31, 2021     67,649,000            
Ending Balance (in shares) at Mar. 31, 2022   3,955,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock awards released and exercise of options (in shares)     154,000            
Issuance of common stock under employee purchase plan (in shares)     59,000            
Issuance of shares to retire Convertible Senior Notes (in shares)     850,000            
Ending Balance (in shares) at Mar. 31, 2022     68,712,000            
Beginning Balance, amount at Dec. 31, 2021   $ 4 $ 68 $ 580,652 $ (37,438) $ (570,668) $ 25,922 $ (45,067) $ (60)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Issuance of common stock under employee purchase plan       77          
Issuance of shares to retire convertible notes     1 1,257          
Equity-based compensation       2,833          
Net loss $ (13,465)         (13,465)      
Net unrealized gain (loss) on debt securities available-for-sale (93)               (93)
Foreign currency translation adjustment (79)               (79)
Ending Balance, amount at Mar. 31, 2022 $ (56,056) $ 4 $ 69 547,381   (558,211)   (45,067) (232)
Beginning Balance (in shares) at Dec. 31, 2022 3,954,546 3,955,000              
Beginning Balance (in shares) at Dec. 31, 2022 97,477,546   97,478,000            
Ending Balance (in shares) at Mar. 31, 2023 3,954,546 3,955,000              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock awards released and exercise of options (in shares)     2,150,000            
Ending Balance (in shares) at Mar. 31, 2023 99,628,248   99,628,000            
Beginning Balance, amount at Dec. 31, 2022 $ (22,264) $ 4 $ 97 630,341   (607,239)   (45,067) (400)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Restricted stock awards released     3            
Equity-based compensation       562          
Net loss (16,795)         (16,795)      
Net unrealized gain (loss) on debt securities available-for-sale 24               24
Foreign currency translation adjustment (255)               (255)
Ending Balance, amount at Mar. 31, 2023 $ (38,725) $ 4 $ 100 $ 630,903   $ (624,034)   $ (45,067) $ (631)